MedPath

Reproducibility of the Measurement of the Right Portal Vein Diameter

Completed
Conditions
Intrauterine Growth Retardation (IUGR)
Interventions
Other: Ultrasound
Registration Number
NCT04617964
Lead Sponsor
Poitiers University Hospital
Brief Summary

Although routine ultrasound is offered during the third trimester of pregnancy, less than a quarter of newborns with intrauterine growth retardation (IUGR) are suspected antenatally.

The measurement of the right portal vein (RPV) diameter on the transverse abdominal view at the 32 weeks' scan may be a new a tool for detecting small-for-gestational-age (SGA) at birth. The irregular and collapsed aspect of the right portal vein (RPV) on the third trimester ultrasound could be used for identifying hypoxemic and growth-restricted fetuses.

However, to our knowledge, the only interoperator reproducibility study of this measurement was performed using the same stored images or datasets without performing a new examination.

The main objective of this study is to assess the intra and interoperator reproducibility of the measurement of the right portal vein diameter at the routine third trimester ultrasound.

The secondary objective is to quantify the interoperator reproducibility of the assessment of the aspect, normal or collapsed, of the right portal vein, using an evaluation grid.

Two referees will perform four successive measurements of the diameter of the right portal vein (RPV) during the same ultrasound examination at the third trimester. Each operator will qualify the appearance of the right portal vein as normal or collapsed using an evaluation grid, and will independently performe a series of two measurements using the same method.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
69
Inclusion Criteria
  • Women carrying a pregnancy from 30 weeks to 33 weeks either normal or with IUGR,
  • Patient without guardianship or curatorship or subordination,
  • Patient benefiting from a Social Security scheme
Exclusion Criteria
  • Presence of a fetal malformation,
  • Multiple pregnancy,
  • Premature rupture of membranes,
  • History of bariatric surgery,
  • Body mass index (BMI)> 30 kg / m2,
  • Patient benefiting from enhanced protection, namely: minors, persons deprived of their liberty by a judicial or administrative decision, persons staying in a health or social establishment, adults under legal protection.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
NORMALUltrasoundSsample of 40 healthy pregnant women Two referees will perform four successive measurements of the diameter of the right portal vein (RPV) during the same ultrasound examination at the third trimester. Each operator will qualify the appearance of the right portal vein as normal or collapsed using an evaluation grid, and will independently performe a series of two measurements using the same method.
IUGRUltrasoundsample of 40 pregnant women affected by intrauterine growth restriction (IUGR) Two referees will perform four successive measurements of the diameter of the right portal vein (RPV) during the same ultrasound examination at the third trimester. Each operator will qualify the appearance of the right portal vein as normal or collapsed using an evaluation grid, and will independently performe a series of two measurements using the same method.
Primary Outcome Measures
NameTimeMethod
Measurement of the right portal vein diameterThrough study completion, an average of 1 year

Intra and interoperator reproducibility of the measurement of the right portal vein diameter at the routine third trimester ultrasound

Secondary Outcome Measures
NameTimeMethod
Aspect of the right portal vein diameterThrough study completion, an average of 1 year

Interoperator reproducibility of the assessment of the aspect, normal or collapsed, of the right portal vein, using an evaluation grid

Trial Locations

Locations (1)

C.H.U. de Poitiers

🇫🇷

Poitiers, France

© Copyright 2025. All Rights Reserved by MedPath